Zobrazeno 1 - 10
of 38
pro vyhledávání: '"P L C M, van Riel"'
Autor:
Marjan Ghiti Moghadam, Femke B. G. Lamers-Karnebeek, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, Barbara van Schaeybroeck, Ruth Klaasen, Marieke van Onna, Hein J. Bernelot Moens, Henk Visser, Annemarie M. Schilder, Marc R. Kok, Robert B. M. Landewé, Piet L. C. M. van Riel, Mart A. F. J. van de Laar, Tim L. Jansen, on behalf of the Dutch National POET Collaboration
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-8 (2019)
Abstract Background The aim of this study was to identify predictors of prolonged disease control after discontinuation of tumor necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis (RA). Methods Post-hoc analysis of 439 R
Externí odkaz:
https://doaj.org/article/ddbedcb42a224131ae7c3a0b9702e2e3
Publikováno v:
RMD Open, Vol 7, Iss 1 (2021)
Obesity is very common in patients with inflammatory rheumatic diseases (IRDs), of which between 27% and 37% of patients have a body mass index ≥30 kg/m2. In addition to further increasing the risk of developing cardiovascular diseases (CVDs) in th
Externí odkaz:
https://doaj.org/article/6c57c2183e07435194861fc71399fe35
Autor:
Marjan Ghiti Moghadam, Femke B G Lamers-Karnebeek, Harald E Vonkeman, Peter M Ten Klooster, Janneke Tekstra, Annemarie M Schilder, Henk Visser, Eric H Sasso, David Chernoff, Willem F Lems, Dirk-Jan van Schaardenburg, Robert Landewe, Hein J Bernelot Moens, Timothy R D J Radstake, Piet L C M van Riel, Mart A F J van de Laar, Tim L Jansen, Dutch National POET Collaboration
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0192425 (2018)
Successfully stopping or reducing treatment for patients with rheumatoid arthritis (RA) in low disease activity (LDA) may improve cost-effectiveness of care. We evaluated the multi-biomarker disease activity (MBDA) score as a predictor of disease rel
Externí odkaz:
https://doaj.org/article/931061a4243b42b79f19e460a8f6321b
Autor:
Cynthia S Crowson, Silvia Rollefstad, George D Kitas, Piet L C M van Riel, Sherine E Gabriel, Anne Grete Semb, A Trans-Atlantic Cardiovascular Risk Consortium for Rheumatoid Arthritis (ATACC-RA)
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175605 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0174656.].
Externí odkaz:
https://doaj.org/article/2de04922f71e4b1c816028681c54d00f
Autor:
Cynthia S Crowson, Silvia Rollefstad, George D Kitas, Piet L C M van Riel, Sherine E Gabriel, Anne Grete Semb, A Trans-Atlantic Cardiovascular Risk Consortium for Rheumatoid Arthritis (ATACC-RA)
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174656 (2017)
OBJECTIVE:Cardiovascular disease (CVD) risk calculators designed for use in the general population do not accurately predict the risk of CVD among patients with rheumatoid arthritis (RA), who are at increased risk of CVD. The process of developing ri
Externí odkaz:
https://doaj.org/article/bd4d21837523478aae848ecf9a78aae8
Autor:
Martijn A H Oude Voshaar, Peter M ten Klooster, Cees A W Glas, Harald E Vonkeman, Erik Taal, Eswar Krishnan, Hein J Bernelot Moens, Maarten Boers, Caroline B Terwee, Piet L C M van Riel, Mart A F J van de Laar
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92367 (2014)
ObjectiveTo calibrate the Dutch-Flemish version of the PROMIS physical function (PF) item bank in patients with rheumatoid arthritis (RA) and to evaluate cross-cultural measurement equivalence with US general population and RA data.MethodsData were c
Externí odkaz:
https://doaj.org/article/10241e7accce406eb0b02ed567ced0aa
Autor:
Jing Cui, Eli A Stahl, Saedis Saevarsdottir, Corinne Miceli, Dorothee Diogo, Gosia Trynka, Towfique Raj, Maša Umiċeviċ Mirkov, Helena Canhao, Katsunori Ikari, Chikashi Terao, Yukinori Okada, Sara Wedrén, Johan Askling, Hisashi Yamanaka, Shigeki Momohara, Atsuo Taniguchi, Koichiro Ohmura, Fumihiko Matsuda, Tsuneyo Mimori, Namrata Gupta, Manik Kuchroo, Ann W Morgan, John D Isaacs, Anthony G Wilson, Kimme L Hyrich, Marieke Herenius, Marieke E Doorenspleet, Paul-Peter Tak, J Bart A Crusius, Irene E van der Horst-Bruinsma, Gert Jan Wolbink, Piet L C M van Riel, Mart van de Laar, Henk-Jan Guchelaar, Nancy A Shadick, Cornelia F Allaart, Tom W J Huizinga, Rene E M Toes, Robert P Kimberly, S Louis Bridges, Lindsey A Criswell, Larry W Moreland, João Eurico Fonseca, Niek de Vries, Barbara E Stranger, Philip L De Jager, Soumya Raychaudhuri, Michael E Weinblatt, Peter K Gregersen, Xavier Mariette, Anne Barton, Leonid Padyukov, Marieke J H Coenen, Elizabeth W Karlson, Robert M Plenge
Publikováno v:
PLoS Genetics, Vol 9, Iss 3, p e1003394 (2013)
Anti-tumor necrosis factor alpha (anti-TNF) biologic therapy is a widely used treatment for rheumatoid arthritis (RA). It is unknown why some RA patients fail to respond adequately to anti-TNF therapy, which limits the development of clinical biomark
Externí odkaz:
https://doaj.org/article/81c1f31b39334e34b1f84c06c37997b4
Autor:
Erik J M Toonen, Christian Gilissen, Barbara Franke, Wietske Kievit, Agnes M Eijsbouts, Alfons A den Broeder, Simon V van Reijmersdal, Joris A Veltman, Hans Scheffer, Timothy R D J Radstake, Piet L C M van Riel, Pilar Barrera, Marieke J H Coenen
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33199 (2012)
So far, there are no means of identifying rheumatoid arthritis (RA) patients who will fail to respond to tumour necrosis factor blocking agents (anti-TNF), prior to treatment. We set out to validate eight previously reported gene expression signature
Externí odkaz:
https://doaj.org/article/f82ca101767b4a1f92e2ffe26a4e189b
Autor:
Judith G M Bergboer, Maša Umićević-Mirkov, Jaap Fransen, Martin den Heijer, Barbara Franke, Piet L C M van Riel, Joost Schalkwijk, Marieke J H Coenen, Nijmegen Biomedical Study principal investigators
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e32045 (2012)
ObjectiveTwo recent studies, in a Spanish and a Chinese population, point to an association between rheumatoid arthritis (RA) risk and the deletion of the Late Cornified Envelope (LCE) 3B and 3C genes (LCE3C_LCE3B-del), a known risk factor for psoria
Externí odkaz:
https://doaj.org/article/a87a4dd435414f628346d0e99f60b8d1
Publikováno v:
Mediators of Inflammation, Vol 2012 (2012)
Cardiovascular (CV) diseases are a serious concern in rheumatoid arthritis (RA), accounting for approximately one-third to one-half of all RA-related deaths. Besides the attempts to identify new risk factors, the proper management of traditional CV r
Externí odkaz:
https://doaj.org/article/d7c68a23ee854c398919cb594744b427